Clinical Trial Detail

NCT ID NCT01662869
Title A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Recruitment Completed
Gender
Phase Phase III
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Onartuzumab

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult

Additional content available in CKB BOOST